Experience

Terren O'Connor

    • Turning Point Therapeutics - $192 Million IPO 


    • TRACON Pharmaceuticals Completes Initial Public Offering 


    • Cooley Advises Xencor on its Initial Public Offering 


    • Eagle $50 Million Initial Public Offering 


    • Flexion $74 Million Initial Public Offering 


    • Auspex $96 Million Initial Public Offering 


    • Cooley Advised Flexion on Initial Public Offering 


    • Cooley Advises Auspex on its Initial Public Offering 


    • Xencor Initial Public Offering 


    • Ambit Initial Public Offering 


    • Receptos, Inc. Initial Public Offering 


    • Cooley Advises Ambit on its IPO 


    • Insys Therapeutics IPO 


    • Hot Topic $600 Million Sale to Sycamore Partners